References
- Cho YJ, Cho YM, Kim SH, Shin KH, Jung ST, Kim HS. Clinical analysis of patients with skeletal metastasis of lung cancer. BMC Cancer. 2019; 19: 303.
- Lee SH. Chemotherapy for lung cancer in the era of personalized medicine. Tuberc Respir Dis. 2019; 82: 179–189.
- Shahedah KK, How SH, Jamalludin AR, Mohd Faiz MT, Kuan YC, Ong CK. Depressive symptoms in newly diagnosed lung carcinoma: Prevalence and associated risk factors. Tuberc Respir Dis. 2019; 82: 217–226.
- Arrieta O, Lopez-Meija M, Macedo-Perez EO, Corona-Cruz JF. Proposals for the prevention of lung Cancer in the Health system of Mexico. Salud Publica de Mexico. 2016; 58: 274–278.
- Ge T, Lin T, Yang J, Wang M. Nutritional status and related factors of patients with advanced lung cancer in northern China: A retrospective study. Cancer Management and Research. 2019; 11: 2225–2231.
- Luo Q, Steinberg J, O'Connel DL, Yu XQ, Caruana M, Wade S, Pesola F, Grogan PB, Dessaix A, Freeman B, et al. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer. 2019; 130: 208–215.
- Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, Salehiniya H, Makhsosi BR, Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Dis. 2016; 8: 1094–1102.
- Dement JM, Ringen K, Hines S, Cranford K, Quinn PS. Lung cancer mortality among construction workers: Implications for early detection. Occup Environ Med. 2020; 77: 207–213.
- Welch LS, Dement JM, Cranford K, Shorter J, Quinn PS, Madtes DK, Ringen K. Early detection of lung cancer in a population at high risk due to occupation and smoking. Occup Environ Med. 2019; 76: 137–142.
- Lehto RH. Symptom burden in lung cancer: Management updates. Lung Cancer Manag. 2016; 5: 61–78.
- Leppert W, Zajaczkowska R, Wordliczek J, Dobrogowski J, Woron J, Krzakowski M. Pathophysiology and clinical characteristics of pain in most common locations in Cancer patients. J Physiol Pharmacol. 2016; 67: 787–799.
- Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily diary study of hope, stigma and functioning in lung cancer patients. Health Psychol. 2018; 37: 218–227.
- Zahir ST, Mirtalebi M. Survival of patients with lung cancer, Yazd, Iran. Asian Pacific J Cancer Prev. 2012; 13: 4387–4391.
- Huang X, Yan A, Liu Q, Liu Q, Wu L. Effects of magnanimous therapy on coping, adjustment and living function in advanced lung cancer. Curr Oncol. 2019; 26: e48–e56.
- Jazinizade M, Malakoutikhah A, Madadimahani A, Iranmanesh MH, Oghabian S, Mohammadshahi F, Janfaza F, Zakeri MA. Stress and quality of life of patients with cancer: the mediating role of mindfulness. J Oncol. 2020; 2020: 3289521.
- Lehto RH. Psychosocial challenges for patients with advanced lung cancer: Interventions to improve well-being. Lung Cancer Targets and Therapy. 2017; 8: 79–90.
- Oancea C, Suciu C, Timar B, Papava I, Raica M, Burlacu O. The reciprocal relationship between coping mechanisms and lung cancer diagnosis: Findings of a prospective study. Cancer Management and Research. 2018; 10: 33–40.
- Abazari M, Gholamnejad M, Roshanaei G, Abazari R, Roosta Y, Mahjub M. Estimation of survival rates in patients with lung cancer in West Azerbaijan, the Northwest of Iran. Asian Pacific J Cancer Prev. 2015; 16: 3923–3926.
- Abedi S, Janbabaei G, Afshari M, Moosazadeh M, Rashidi Alashti M, Hedayatizadeh-Omran A, Alizadeh-Navaei R, Abedini E. Estimating the survival of patients with lung cancer: what is the best statistical model? J Prev Med Public Health. 2019; 52: 140–144.
- Hellmann MD, Li BT, Chaft JE, Kris MG. Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol. 2016; 27: 1829–1835.
- Chabowski M, Polanski J, Jankowska-Polanska B, Lomper K, Janczak D, Rosinczuk J. The acceptance of illness, the intensity of pain and the quality of life in patients with lung cancer. J Thorac Dis. 2017; 9: 2952–2958.
- Gu W, Xu YM, Zhu JH, Zhong BL. Depression and its impact on health-related quality of life among Chinese inpatients with lung cancer. Oncotarget. 2017; 8: 104806–12.
- Udupa K, Rajendranath R, Sagar TG. Comparison study of quality of life in advanced lung cancer patients on tyrosine kinase inhibitor and platinum doublet chemotherapy. Indian J Cancer. 2017; 54: 161–163.
- Yun YH, Kim YA, Sim JA, Shin AS, Chang YJ, Lee J, Kim MS, Shim YM, Zo JL. Prognostic value of quality of life score in disease-free survivors of surgically treated lung cancer. BMC Cancer. 2016; 16: 505.
- Wilmowska-Pietruszyńska A. Health, financial and social situation of the disabled and the dependent in Poland. Orzecznictwo Lekarskie. 2009; 6: 1–12.
- Wilmowska-Pietruszyńska A. Social security for the disabled and the dependent in Poland. Orzecznictwo Lekarskie. 2007; 4: 13–25.
- Wilmowska-Pietruszyńska A. The risk of incapacity for independent living-necessity of social protection. Polityka Zdrowotna. 2012; 10: 41–55.
- Giuliani ME, Milne RA, Puts M, Sampson LR, Kwan JYY, Le LW, Alibhai SMH, Howell D, Abdelmutti N, Liu G, et al. The prevalence and nature of supportive care needs in lung cancer patients. Curr Oncol. 2016; 23: 258–265.
- Tradecki M, Ziółkowska J, Roemer-Ślimak R, Mazur G, Butrym A. Inability to live independently in the course of breast cancer: Main risk factors. Pol Arch Intern Med. 2021; 131: 16118.
- Mahoney FI, Barthel DQ. Functional evaluation: The Barthel Index. Md State Med. J. 1965; 14: 61–65.
- Lundin A, Driscoll B. Lung cancer stem cells: progress and prospects. Cancer Lett. 2013; 338: 89–93.
- Lim RBL. End-of-life care in patients with advanced lung cancer. Adv Respir Dis. 2016; 10: 455–467.